Published in J Immunol Res on April 27, 2014
International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights (2016) 0.93
Confirmation of anti-DFS70 antibodies is needed in routine clinical samples with DFS staining pattern. Cent Eur J Immunol (2016) 0.79
How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit. Clin Exp Immunol (2015) 0.79
Single-cell antibody nanowells: a novel technology in detecting anti-SSA/Ro60- and anti-SSB/La autoantibody-producing cells in peripheral blood of rheumatic disease patients. Arthritis Res Ther (2016) 0.76
B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis. Medicine (Baltimore) (2016) 0.75
The Reliability of a Novel Automated System for ANA Immunofluorescence Analysis in Daily Clinical Practice. Int J Rheumatol (2016) 0.75
Simultaneous detection of celiac disease-specific IgA antibodies and total IgA. Auto Immun Highlights (2016) 0.75
Current practice in laboratory diagnostics of autoimmune diseases in Croatia. Survey of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb) (2016) 0.75
ANA IIF Automation: Moving towards Harmonization? Results of a Multicenter Study. J Immunol Res (2017) 0.75
Detection of autoantibodies using chemiluminescence technologies. Immunopharmacol Immunotoxicol (2015) 0.75
Emerging technologies in autoantibody testing for rheumatic diseases. Arthritis Res Ther (2017) 0.75
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology. Clin Rev Allergy Immunol (2017) 0.75
[Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70]. Z Rheumatol (2016) 0.75
Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis. J Neurol (2017) 0.75
Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto Immun Highlights (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med (1950) 43.56
Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 10.82
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85
Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med (2002) 4.54
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum (2011) 4.02
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis (2013) 3.99
Culture characteristics of four permanent lines of human cancer cells. Cancer Res (1955) 3.69
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum (2004) 3.23
Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum (2002) 2.99
Interaction of nuclei and globulin from lupus erythematosis serum demonstrated with fluorescent antibody. J Immunol (1958) 2.77
The clinical utility of a positive antinuclear antibody test result. Am J Med (2013) 2.23
ANA screening: an old test with new recommendations. Ann Rheum Dis (2010) 2.21
The L. E. cell and the L. E. serum factors. Bull N Y Acad Med (1959) 2.12
Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med (2000) 2.07
Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta (2012) 1.88
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med (2013) 1.75
Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate (2005) 1.48
Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence. Rheumatology (Oxford) (2009) 1.47
Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Res Ther (2008) 1.47
Autoantibodies in systemic vasculitis. Aust N Z J Med (1991) 1.44
Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer (1993) 1.37
Presentation of two bone marrow elements; the tart cell and the L.E. cell. Proc Staff Meet Mayo Clin (1948) 1.35
Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther (2010) 1.29
Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum (2004) 1.29
Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev (2009) 1.28
A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol (2011) 1.27
Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum (2004) 1.26
Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther (2011) 1.25
Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22
Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev (2009) 1.21
Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev (2011) 1.19
From ANA to ENA: how to proceed? Autoimmun Rev (2005) 1.18
Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci (2010) 1.17
The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol (2012) 1.15
Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods (2009) 1.14
Detection of antinuclear antibodies: added value of solid phase assay? Ann Rheum Dis (2013) 1.13
Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods (2010) 1.13
Mining knowledge for HEp-2 cell image classification. Artif Intell Med (2002) 1.12
LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun Rev (2003) 1.12
Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus (2006) 1.12
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus (2008) 1.11
A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev (2012) 1.10
Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun (2010) 1.10
Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Res Ther (2004) 1.08
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev (2012) 1.07
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. Arthritis Rheum (1997) 1.07
Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol (2012) 1.05
Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol (2011) 1.05
Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Ann N Y Acad Sci (2007) 1.05
The antinuclear antibody test: last or lasting gasp? Arthritis Rheum (2011) 1.05
New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol (2012) 1.04
Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin Diagn Lab Immunol (2002) 1.04
Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta (2010) 1.03
Analysis of human sera that are polyreactive in an addressable laser bead immunoassay. Clin Immunol (2006) 1.01
Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum (2004) 1.01
Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods (2006) 1.01
AutoAbSC.Org -- Autoantibody Standardization Committee in 2006. Autoimmun Rev (2007) 1.00
Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol (2004) 1.00
Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity (2005) 0.99
Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease. Acta Pathol Microbiol Immunol Scand C (1983) 0.99
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun (2009) 0.98
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun (1999) 0.97
Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. J Autoimmun (2004) 0.96
Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev (2012) 0.96
Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system. Clin Dev Immunol (2004) 0.95
Evaluation of microarray surfaces and arraying parameters for autoantibody profiling. Proteomics (2008) 0.95
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum (2012) 0.93
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol (2009) 0.93
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol (2003) 0.93
Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion (1985) 0.92
Detection and identification of significant ANAs in previously determined ANA negative samples. Clin Lab (2005) 0.92
The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr Med Chem (2006) 0.92
Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Ann Thorac Surg (2000) 0.92
Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun (2004) 0.92
Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis. Clin Rheumatol (2011) 0.91
Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev (2011) 0.91
Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality? Autoimmun Rev (2010) 0.91
Benchmarking HEp-2 cells classification methods. IEEE Trans Med Imaging (2013) 0.91
Antibodies to the lens and cornea in anti-DFS70-positive subjects. Ann N Y Acad Sci (2007) 0.90
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nat Rev Rheumatol (2013) 0.90
Development of the antinuclear and anticytoplasmic antibody consensus panel by the Association of Medical Laboratory Immunologists. Clin Diagn Lab Immunol (2000) 0.90
Standardization of automated interpretation of immunofluorescence tests. Clin Chim Acta (2013) 0.90
Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem (2004) 0.90
Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clin Chem Lab Med (2014) 0.89
Antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum (1959) 0.89
Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol (1997) 0.89
Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus (2004) 0.89
Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun Rev (2010) 0.89
Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun (2004) 0.89
Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay. Cytometry A (2011) 0.89
An anti-nuclear antibody-negative patient with systemic lupus erythematosus (SLE) accompanied with anti-ribosomal P antibody (anti-P). Intern Med (2002) 0.89
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay. Arthritis Res Ther (2013) 0.88
Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem (2002) 0.88
Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus (2003) 0.88
Digital immunofluorescence enables automated detection of antinuclear antibody endpoint titers avoiding serial dilution. Clin Chem Lab Med (2014) 0.87
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J Autoimmun (2008) 0.87
Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev (2009) 0.86
Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies. J Immunol Res (2014) 0.86
Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies. J Immunol Res (2014) 0.82
Analytical and clinical comparison of two fully automated immunoassay systems for the diagnosis of celiac disease. J Immunol Res (2014) 0.81
Mercury, autoimmunity, and environmental factors on cheyenne river sioux tribal lands. Autoimmune Dis (2014) 0.79
Autoantibodies in systemic autoimmune disorders. J Immunol Res (2014) 0.76